3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
7
Pulmonary Embolism
5
Venous Thrombosis
4
Neoplasms
4
Neoplasm Metastasis
2
Thrombosis
1
Sarcoma
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Mesenteric Ischemia
1
Lymphoma
1
Intracranial Thrombosis
1
Fractures, Spontaneous
1
Femoral Fractures
1
Bone Neoplasms
1
Acute Deep Vein Thrombosis
1
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
Dalteparin
×
Clear all
No trials found.